Strong Growth Lies Ahead of Nigerian Pharmaceutical Sector – Report

1 Min Read

Research and Markets in its latest report titled “The Pharmaceutical Market: Nigeria” insisted that strong growth lies ahead of the Nigerian pharmaceutical sector because of the rapidly growing population and emerging middle class in the country.

The report recommended that the government needs to address urgent issues such as brain drain of health professionals and inadequate funding of the public system affecting the health sector.

The report also acknowledged the government’s endeavours to crack down on counterfeit drugs and reduce medical tourism out of the country.

The pharmaceutical companies mentioned in the report include Drugfield Pharmaceuticals, Emzor Pharmaceutical Industries, Fidson Healthcare, GlaxoSmithKline, May & Baker, Merck & Co, Neimeth Pharmaceuticals, Neros Pharmaceuticals.

Others are Nigerian-German Chemicals (NGC), Novartis, Pfizer and Sanofi.

Share this Article
Leave a comment

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.